Duopharma Biotech Berhad (7148.KL)
MYR 1.24
(-0.8%)
MYR 1.24
(-0.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 658.01 Million MYR | 16.11% |
| 2022 | 566.69 Million MYR | 4.92% |
| 2021 | 540.12 Million MYR | 30.27% |
| 2020 | 414.61 Million MYR | 6.3% |
| 2019 | 390.05 Million MYR | 9.77% |
| 2018 | 355.33 Million MYR | 57.66% |
| 2017 | 225.37 Million MYR | 8.9% |
| 2016 | 206.94 Million MYR | 12.64% |
| 2015 | 183.72 Million MYR | 536.91% |
| 2014 | 28.84 Million MYR | 25.41% |
| 2013 | 23 Million MYR | -16.43% |
| 2012 | 27.52 Million MYR | -16.77% |
| 2011 | 33.07 Million MYR | -14.34% |
| 2010 | 38.61 Million MYR | 26.07% |
| 2009 | 30.62 Million MYR | 54.46% |
| 2008 | 19.82 Million MYR | 51.11% |
| 2007 | 13.12 Million MYR | -3.36% |
| 2006 | 13.57 Million MYR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 649.75 Million MYR | 2.88% |
| 2024 Q1 | 631.59 Million MYR | -4.02% |
| 2023 Q2 | 574.88 Million MYR | 0.29% |
| 2023 Q3 | 708.98 Million MYR | 23.33% |
| 2023 Q1 | 573.23 Million MYR | 1.15% |
| 2023 FY | 658.01 Million MYR | 16.11% |
| 2023 Q4 | 658.01 Million MYR | -7.19% |
| 2022 Q1 | 568.5 Million MYR | 5.25% |
| 2022 FY | 566.69 Million MYR | 4.92% |
| 2022 Q4 | 566.69 Million MYR | -1.05% |
| 2022 Q3 | 572.7 Million MYR | 1.14% |
| 2022 Q2 | 566.27 Million MYR | -0.39% |
| 2021 Q4 | 540.12 Million MYR | -4.71% |
| 2021 FY | 540.12 Million MYR | 30.27% |
| 2021 Q2 | 482.95 Million MYR | 3.38% |
| 2021 Q1 | 467.17 Million MYR | 12.68% |
| 2021 Q3 | 566.84 Million MYR | 17.37% |
| 2020 FY | 414.61 Million MYR | 6.3% |
| 2020 Q1 | 418.45 Million MYR | 7.28% |
| 2020 Q2 | 423.39 Million MYR | 1.18% |
| 2020 Q3 | 402.83 Million MYR | -4.85% |
| 2020 Q4 | 414.61 Million MYR | 2.92% |
| 2019 Q2 | 406.99 Million MYR | 7.72% |
| 2019 FY | 390.05 Million MYR | 9.77% |
| 2019 Q4 | 390.05 Million MYR | -2.27% |
| 2019 Q3 | 399.12 Million MYR | -1.93% |
| 2019 Q1 | 377.82 Million MYR | 6.33% |
| 2018 Q1 | 254.39 Million MYR | 12.88% |
| 2018 FY | 355.33 Million MYR | 57.66% |
| 2018 Q4 | 355.33 Million MYR | 6.05% |
| 2018 Q3 | 335.05 Million MYR | 5.81% |
| 2018 Q2 | 316.66 Million MYR | 24.48% |
| 2017 FY | 225.37 Million MYR | 8.9% |
| 2017 Q4 | 225.37 Million MYR | -5.02% |
| 2017 Q3 | 237.28 Million MYR | 4.78% |
| 2017 Q2 | 226.46 Million MYR | -1.61% |
| 2017 Q1 | 230.17 Million MYR | 11.22% |
| 2016 FY | 206.94 Million MYR | 12.64% |
| 2016 Q4 | 206.94 Million MYR | 11.26% |
| 2016 Q1 | 184.86 Million MYR | 0.62% |
| 2016 Q2 | 185.68 Million MYR | 0.44% |
| 2016 Q3 | 186 Million MYR | 0.17% |
| 2015 FY | 183.72 Million MYR | 536.91% |
| 2015 Q1 | 34.42 Million MYR | 19.32% |
| 2015 Q2 | 351.68 Million MYR | 921.75% |
| 2015 Q3 | 212.34 Million MYR | -39.62% |
| 2015 Q4 | 183.72 Million MYR | -13.48% |
| 2014 Q4 | 28.84 Million MYR | -25.15% |
| 2014 Q3 | 38.53 Million MYR | 0.11% |
| 2014 Q2 | 38.49 Million MYR | 10.63% |
| 2014 Q1 | 34.79 Million MYR | 51.27% |
| 2014 FY | 28.84 Million MYR | 25.41% |
| 2013 Q4 | 23 Million MYR | -37.68% |
| 2013 Q2 | 25.77 Million MYR | -3.12% |
| 2013 Q3 | 36.91 Million MYR | 43.2% |
| 2013 FY | 23 Million MYR | -16.43% |
| 2013 Q1 | 26.6 Million MYR | -3.35% |
| 2012 FY | 27.52 Million MYR | -16.77% |
| 2012 Q2 | 35 Million MYR | 14.3% |
| 2012 Q3 | 26.17 Million MYR | -25.23% |
| 2012 Q1 | 30.62 Million MYR | 0.0% |
| 2012 Q4 | 27.52 Million MYR | 5.17% |
| 2011 FY | 33.07 Million MYR | -14.34% |
| 2010 FY | 38.61 Million MYR | 26.07% |
| 2009 FY | 30.62 Million MYR | 54.46% |
| 2008 FY | 19.82 Million MYR | 51.11% |
| 2007 FY | 13.12 Million MYR | -3.36% |
| 2006 FY | 13.57 Million MYR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Kotra Industries Berhad | 63.54 Million MYR | -935.44% |